Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
Harnessing different abilities
Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...
Aged care in focus
The Royal Commission into Aged Care Quality and Safety has heard clear calls for pharmacists, as a priority, to spend more time on the...
PSA’s projects make a bigger impact than ever before
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.
Resistance movement: Pharmacy’s fight against antimicrobial resistance
Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...













